BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 32120274)

  • 1. The cost of cancer in Europe 2018.
    Hofmarcher T; Lindgren P; Wilking N; Jönsson B
    Eur J Cancer; 2020 Apr; 129():41-49. PubMed ID: 32120274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic burden of malignant blood disorders across Europe: a population-based cost analysis.
    Burns R; Leal J; Sullivan R; Luengo-Fernandez R
    Lancet Haematol; 2016 Aug; 3(8):e362-70. PubMed ID: 27476787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The economic burden of colorectal cancer across Europe: a population-based cost-of-illness study.
    Henderson RH; French D; Maughan T; Adams R; Allemani C; Minicozzi P; Coleman MP; McFerran E; Sullivan R; Lawler M
    Lancet Gastroenterol Hepatol; 2021 Sep; 6(9):709-722. PubMed ID: 34329626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cost and burden of cancer in the European Union 1995-2014.
    Jönsson B; Hofmarcher T; Lindgren P; Wilking N
    Eur J Cancer; 2016 Oct; 66():162-70. PubMed ID: 27589247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost of disorders of the brain in Europe 2010.
    Gustavsson A; Svensson M; Jacobi F; Allgulander C; Alonso J; Beghi E; Dodel R; Ekman M; Faravelli C; Fratiglioni L; Gannon B; Jones DH; Jennum P; Jordanova A; Jönsson L; Karampampa K; Knapp M; Kobelt G; Kurth T; Lieb R; Linde M; Ljungcrantz C; Maercker A; Melin B; Moscarelli M; Musayev A; Norwood F; Preisig M; Pugliatti M; Rehm J; Salvador-Carulla L; Schlehofer B; Simon R; Steinhausen HC; Stovner LJ; Vallat JM; Van den Bergh P; van Os J; Vos P; Xu W; Wittchen HU; Jönsson B; Olesen J;
    Eur Neuropsychopharmacol; 2011 Oct; 21(10):718-79. PubMed ID: 21924589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic burden of non-malignant blood disorders across Europe: a population-based cost study.
    Luengo-Fernandez R; Burns R; Leal J
    Lancet Haematol; 2016 Aug; 3(8):e371-8. PubMed ID: 27476788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic burden of cancer across the European Union: a population-based cost analysis.
    Luengo-Fernandez R; Leal J; Gray A; Sullivan R
    Lancet Oncol; 2013 Nov; 14(12):1165-74. PubMed ID: 24131614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating the cost of epilepsy in Europe: a review with economic modeling.
    Pugliatti M; Beghi E; Forsgren L; Ekman M; Sobocki P
    Epilepsia; 2007 Dec; 48(12):2224-33. PubMed ID: 18088267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measuring the societal burden of cancer: the cost of lost productivity due to premature cancer-related mortality in Europe.
    Hanly P; Soerjomataram I; Sharp L
    Int J Cancer; 2015 Feb; 136(4):E136-45. PubMed ID: 25066804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Projections of the cost of cancer care in the United States: 2010-2020.
    Mariotto AB; Yabroff KR; Shao Y; Feuer EJ; Brown ML
    J Natl Cancer Inst; 2011 Jan; 103(2):117-28. PubMed ID: 21228314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Projecting productivity losses for cancer-related mortality 2011 - 2030.
    Pearce A; Bradley C; Hanly P; O'Neill C; Thomas AA; Molcho M; Sharp L
    BMC Cancer; 2016 Oct; 16(1):804. PubMed ID: 27756270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost of schizophrenia in England.
    Mangalore R; Knapp M
    J Ment Health Policy Econ; 2007 Mar; 10(1):23-41. PubMed ID: 17417045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic cost of Guillain-Barré syndrome in the United States.
    Frenzen PD
    Neurology; 2008 Jul; 71(1):21-7. PubMed ID: 18591502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic Burden of Bladder Cancer Across the European Union.
    Leal J; Luengo-Fernandez R; Sullivan R; Witjes JA
    Eur Urol; 2016 Mar; 69(3):438-47. PubMed ID: 26508308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Academic achievement and productivity losses associated with speech, language and communication needs.
    Cronin P; Reeve R; McCabe P; Viney R; Goodall S
    Int J Lang Commun Disord; 2020 Sep; 55(5):734-750. PubMed ID: 32687245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Annual productivity costs due to cervical cancer mortality in the United States.
    Insinga RP
    Womens Health Issues; 2006; 16(5):236-42. PubMed ID: 17055376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Economic Burden of Asthma in the United States, 2008-2013.
    Nurmagambetov T; Kuwahara R; Garbe P
    Ann Am Thorac Soc; 2018 Mar; 15(3):348-356. PubMed ID: 29323930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost of headache disorders in Europe: the Eurolight project.
    Linde M; Gustavsson A; Stovner LJ; Steiner TJ; Barré J; Katsarava Z; Lainez JM; Lampl C; Lantéri-Minet M; Rastenyte D; Ruiz de la Torre E; Tassorelli C; Andrée C
    Eur J Neurol; 2012 May; 19(5):703-11. PubMed ID: 22136117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Projected Impact on Labour Productivity Costs of Cancer-Related Premature Mortality in Europe 2018-2040.
    Ortega-Ortega M; Hanly P; Pearce A; Soerjomataram I; Sharp L
    Appl Health Econ Health Policy; 2023 Nov; 21(6):877-889. PubMed ID: 37552416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cost of premature death from cancer attributable to alcohol: Productivity losses in Europe in 2018.
    Rumgay H; Ortega-Ortega M; Sharp L; Lunet N; Soerjomataram I
    Cancer Epidemiol; 2023 Jun; 84():102365. PubMed ID: 37058915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.